The Healthcare Education Services, an entity certified by the Faculty of Pharmaceutical Medicine for Continuing Professional Development, is offering a course on Alzheimer’s designed for professionals who deal with patients suffering from the disease, as well as for researchers. “Alzheimer’s Disease: An Overview” is taking place between October 1…
An independent expert from the United Nations recently alerted the organization’s member states on the need to protect dementia patients, especially older ones, from stigmatization, discrimination, victimization, and neglect, as he spoke to celebrate the World Alzheimer’s Day, which is marked annually on September 21th. The UN believes that concerted actions are needed in…
A research project designed to create a molecular map with thousands of proteins in the brain with Alzheimer’s disease, conducted by Dr. Richard Unwin, from The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust has been granted a £30,000 ($48,600 dollars) award by Alzheimer’s Research UK. The…
A novel, wearable sensor system created for dementia patients helps to keep them safe when they wander out of bed during the night while also providing relief to their families and caregivers. The system, which connects to a smartphone, is not only innovative, but is also…
Pennsylvania-based Representative Chaka Fattah — a U.S. Congressman behind the Fattah Neuroscience Initiative, which aims to drive collaborative Federal research on brain cognition, development, disease and injury — recently had a meeting with World Dementia Envoy and head of the World Dementia Council, Dr. Dennis Gillings, to…
AstraZeneca and Eli Lilly and Company have reached an agreement for the development and commercialization of the oral beta secretes cleaving enzyme (BACE) inhibitor, AZD3293, which might become a viable treatment for Alzheimer’s disease. The oral therapy is expected to prevent the formation of…
The human brain has the plasticity to compensate for the accumulation of the protein beta-amyloid that causes Alzheimer’s disease, which explains that some individuals develop it and others don’t, as concluded by research conducted at the University of California in Berkeley (UC Berkeley). The researchers analyzed adults with and without beta-amyloid deposits…
The Alzheimer’s Drug Discovery Foundation (ADDF) and the Boston-based software company OnDeckBiotech are launching a new open access platform with the purpose of creating an improved way to connect scientists with a virtual network of contract research organizations (CROs), drug development experts, and educational resources. The announcement was made on third day of…
For diseases that science has yet to find a cure, researchers are hard at work developing preventive medicine, better diagnostic tools, and risk calculation methods. A biotech company that specializes in advancing serum-based assays for neurodegenerative conditions has just announced an exclusive Fall 2014 release of a patented test that can predict the development…
Featureflash / Shutterstock.com Actress Julianne Moore is starring a movie about the struggle against Alzheimer’s disease, a drama about a 50-year-old college professor who is diagnosed with Early-onset Familial Alzheimer’s. In addition, the movie is looking to raise awareness about the disease and show what it…
Get regular updates to your inbox.